☆ 4.7 Article

Humoral and Cellular Response after mRNA Vaccination in Nursing Homes: Influence of Age and of History of COVID-19

VACCINES (2022)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Microbiology

A Pilot Study for the Evaluation of an Interferon Gamma Release Assay (IGRA) To Measure T-Cell Immune Responses after SARS-CoV-2 Infection or Vaccination in a Unique Cloistered Cohort

Pablo Barreiro et al.

Summary: Assessing T-cell responses to SARS-CoV-2 antigens is important for determining long-lasting protection against breakthrough infections or reinfections. The interferon gamma release assay, a validated method for testing cellular immunity in mycobacterial infections, has been proposed for patients with SARS-CoV-2 infection or vaccination.

JOURNAL OF CLINICAL MICROBIOLOGY (2022)

添加到收藏夹

Article Allergy

Antibody response after one and two jabs of the BNT162b2 vaccine in nursing home residents: The CONsort-19 study

Hubert Blain et al.

Summary: Residents in nursing homes with prior COVID-19 had higher humoral immune response levels after vaccination compared to those without prior infection. Majority of residents without prior COVID-19 developed antibodies after the second jab, but around 30% had low levels. Further analysis is needed to determine if residents with low post-vaccine antibody levels are at higher risk for symptomatic COVID-19.

ALLERGY (2022)

添加到收藏夹

Article Immunology

Long-Term Persistence of Spike Protein Antibody and Predictive Modeling of Antibody Dynamics After Infection With Severe Acute Respiratory Syndrome Coronavirus 2

Louis Grandjean et al.

Summary: The Co-Stars study reveals long-term persistence of neutralizing S antibodies after SARS-CoV-2 infection, with implications for functional immunity duration. In contrast, nucleoprotein antibodies decay rapidly, emphasizing the need to consider this in future seroprevalence studies and public health decision-making. This study is the first to establish a mathematical framework capable of predicting long-term humoral dynamics post-SARS-CoV-2 infection.

CLINICAL INFECTIOUS DISEASES (2022)

添加到收藏夹

Letter Infectious Diseases

Prior SARS-CoV-2 infection is associated with protection against symptomatic reinfection

Aidan T. Hanrath et al.

JOURNAL OF INFECTION (2021)

添加到收藏夹

Article Infectious Diseases

Antibodies to SARS-CoV-2 protect against re-infection during outbreaks in care homes, September and October 2020

Anna Jeffery-Smith et al.

Summary: The study found that individuals who had prior exposure to SARS-CoV-2 had a significantly lower risk of re-infection after a second outbreak in two care homes in London. The protection offered by prior infection against re-infection was estimated to be around 96%, based on different statistical models.

EUROSURVEILLANCE (2021)

添加到收藏夹

Article Medicine, General & Internal

Waning Immunity after the BNT162b2 Vaccine in Israel

Yair Goldberg et al.

Summary: The immunity against the delta variant of SARS-CoV-2 waned in all age groups in Israel a few months after receiving the second dose of the vaccine, leading to an increase in infection and severe cases.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

添加到收藏夹

Article Multidisciplinary Sciences

mRNA vaccines induce durable immune memory to SARS-CoV-2 and variants of concern

Rishi R. Goel et al.

Summary: This study found that immune memory to SARS-CoV-2 and its variants remains robust for at least 6 months after mRNA vaccination, with antibodies declining but still detectable in most individuals. mRNA vaccines also induced functional memory B cells and antigen-specific T cells, with recall responses primarily increasing antibody levels in individuals with preexisting immunity.

SCIENCE (2021)

添加到收藏夹

Article Public, Environmental & Occupational Health

Suspected Recurrent SARS-CoV-2 Infections Among Residents of a Skilled Nursing Facility During a Second COVID-19 Outbreak — Kentucky, July–November 2020

Alyson M. Cavanaugh et al.

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2021)

添加到收藏夹

Article Geriatrics & Gerontology

The demography and characteristics of SARS-CoV-2 seropositive residents and staff of nursing homes for older adults in the Community of Madrid: the SeroSOS study

Francisco Javier Candel et al.

Summary: The study highlights the high prevalence of COVID-19 among residents in nursing homes, especially those who are frail and have comorbidities. Factors associated with seropositivity among staff include age, obesity, job type, workplace seroprevalence, and contact with external COVID-19 cases. Strengthening control measures is crucial to prevent COVID-19 transmission in care facilities.

AGE AND AGEING (2021)

添加到收藏夹

Editorial Material Immunology

Reduced BNT162b2 Messenger RNA Vaccine Response in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)-Naive Nursing Home Residents

David H. Canaday et al.

Summary: After receiving the BNT162b2 messenger RNA vaccine, nursing home residents had antibody neutralization titers one-quarter of healthcare workers who were naive to SARS-CoV-2.

CLINICAL INFECTIOUS DISEASES (2021)

添加到收藏夹

Article Infectious Diseases

SARS-CoV-2 antibody dynamics and B-cell memory response over time in COVID-19 convalescent subjects

Anat Achiron et al.

Summary: The majority of convalescent COVID-19 subjects maintain a long-term IgG antibody response to SARS-CoV-2, with a protective level lasting up to 9 months, regardless of age, gender, major blood types, or clinical symptomatology.

CLINICAL MICROBIOLOGY AND INFECTION (2021)

添加到收藏夹

Article Medicine, General & Internal

Assessment of protection against reinfection with SARS-CoV-2 among 4 million PCR-tested individuals in Denmark in 2020: a population-level observational study

Christian Holm Hansen et al.

Summary: The study investigated the protection against SARS-CoV-2 reinfection, with results showing an 80.5% protection rate for individuals previously infected. Even in the population aged 65 years and older, the protection rate against reinfection reached 47.1%, with no significant differences observed by gender or time since infection.

LANCET (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection

David S. Khoury et al.

Summary: The level of neutralizing antibodies is closely related to immune protection against COVID-19, playing a crucial role in protecting against detected infection and severe infection. Studies have shown that neutralizing titers will decline over time after vaccination, leading to decreased protection against SARS-CoV-2 infection.

NATURE MEDICINE (2021)

添加到收藏夹

Article Public, Environmental & Occupational Health

Changes in symptomatology, reinfection, and transmissibility associated with the SARS-CoV-2 variant B.1.1.7: an ecological study

Mark S. Graham et al.

Summary: The study showed that the B.1.1.7 variant did not result in changes in COVID-19 symptoms or duration of illness, and there was no significant increase in reinfection rate compared to previous variants.

LANCET PUBLIC HEALTH (2021)

添加到收藏夹

Editorial Material Biochemistry & Molecular Biology

COVID-19 vaccines: Keeping pace with SARS-CoV-2 variants Comment

Muge Cevik et al.

Summary: As the SARS-CoV-2 pandemic progresses, new variants are emerging, with some highly transmissible variants like Delta raising concerns about vaccine effectiveness. Understanding the immunological correlates of protection and how laboratory findings relate to clinical effectiveness is crucial for shaping future vaccination strategies.

CELL (2021)

添加到收藏夹

Article Immunology

Antibody Response to SARS-CoV-2 is Associated with Long-term Clinical Outcome in Patients with COVID-19: a Longitudinal Study

Javier Garcia-Abellan et al.

Summary: Long-COVID is associated with weak anti-SARS-CoV-2 antibody response, severity of illness, and female gender. Late clinical events and persistent symptoms in the medium and long term occur in a significant proportion of patients hospitalized for COVID-19.

JOURNAL OF CLINICAL IMMUNOLOGY (2021)

添加到收藏夹

Article Immunology

Dynamics of the Cellular and Humoral Immune Response After BNT162b2 Messenger Ribonucleic Acid Coronavirus Disease 2019 (COVID-19) Vaccination in COVID-19-Naive Nursing Home Residents

Jens T. Van Praet et al.

Summary: Short-term humoral and cellular immune responses in COVID-19-naive nursing home residents decrease after BNT162b2 vaccination, with an estimated antibody response half-life of 47 days. Older age is associated with a decreased humoral response at 4 weeks, while diabetes mellitus and active malignancy are linked to a decreased cellular response. Boosters may be necessary for this vulnerable population.

JOURNAL OF INFECTIOUS DISEASES (2021)

添加到收藏夹

Letter Geriatrics & Gerontology

SARS-CoV-2 B 1.1.7 Variant Outbreak in a Fully Vaccinated Nursing Home-Madrid, June 2021

Jesus Mateos-Nozal et al.

JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION (2021)

添加到收藏夹

Article Medicine, General & Internal

Protection of BNT162b2 Vaccine Booster against Covid-19 in Israel

Yinon M. Bar-On et al.

Summary: After receiving a third dose of the BNT162b2 mRNA vaccine, Israeli residents aged 60 and above who had previously received two doses of the vaccine saw significantly lower rates of confirmed Covid-19 infection and severe illness compared to those who did not receive a booster shot, indicating the effectiveness of the booster dose in reducing infection and severe illness.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

添加到收藏夹

Article Medicine, General & Internal

Associations of BNT162b2 vaccination with SARS-CoV-2 infection and hospital admission and death with covid-19 in nursing homes and healthcare workers in Catalonia: prospective cohort study

Carmen Cabezas et al.

Summary: Vaccination showed a significant reduction of 80-91% in SARS-CoV-2 infection across all three cohorts, with greater reductions in hospital admissions and mortality among nursing home residents.

BMJ-BRITISH MEDICAL JOURNAL (2021)

添加到收藏夹

Article Infectious Diseases

Preliminary Evaluation of QuantiFERON SARS-CoV-2 and QIAreach Anti-SARS-CoV-2 Total Test in Recently Vaccinated Individuals

Soumya Jaganathan et al.

Summary: This study evaluated total antibody and T cell responses in COVID-19 convalescents and vaccinated individuals, finding robust immune responses to SARS-CoV-2 mRNA vaccines in vaccinated subjects and sustained responses in convalescent donors for up to 1 year post-infection.

INFECTIOUS DISEASES AND THERAPY (2021)

添加到收藏夹

Article Microbiology

Detection of SARS-CoV-2 IgG Targeting Nucleocapsid or Spike Protein by Four High-Throughput Immunoassays Authorized for Emergency Use

Harry E. Prince et al.

JOURNAL OF CLINICAL MICROBIOLOGY (2020)

添加到收藏夹

Review Biotechnology & Applied Microbiology

The Impact of COVID-19 Pandemic on Long-Term Care Facilities Worldwide: An Overview on International Issues

Dana-Claudia Thompson et al.

BIOMED RESEARCH INTERNATIONAL (2020)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.